Temporalis Muscle Thickness as a Prognostic Factor for 30-day, 90-day, and Overall Mortality in Newly-Diagnosed Glioblastoma

Abstract excerpt

<h4>Background: </h4> The identification of novel prognostic biomarkers for glioblastoma (GBM) can guide clinicians and patients in treatment approaches. Frailty, as measured by sarcopenia, has been proven to predict overall survival in other oncologic processes. Objective We evaluated whether sarcopenia, as measured by temporalis muscle thickness, predicted survival in GBM, and we compared its accuracy to other...

Topics

Open a Topic to create a Post that cites this publication.

• Body Mass Index
• Brain Neoplasms
• Cachexia
• Obesity
• Postoperative Complications
• Risk Factors
• Sarcopenia
• Treatment Outcome

Identifiers and source

Literature Corpus work

b1b4ebb1-d2ca-5862-89ec-c3f01b1f03b4

DOI

10.21203/rs.3.rs-3895323/v1